MYCN and neuroblastoma: Our observations that genetic determinants of both taller pre‐pubertal height and shorter adult height were independently associated with risk of MYCN‐amplified neuroblastoma reinforce the idea that distinct genetic risk factors and biological pathways underlie risk of MYCN‐amplified vs unamplified neuroblastoma.